Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FUJSX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,341
Award facts
- Contract value 100% obligated
- $12,340.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $12,340.86 for Xiaflex 0.9 mg vials. Awarded on September 25, 2025, with an ultimate completion date of October 17, 2025, this firm fixed-price delivery order was issued without a set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems. The Xiaflex delivery represents one of numerous pharmaceutical product acquisitions under the SPE2DB IDC, which covers an extensive portfolio including injections, tablets, specialty medications, and other pharmacy products. The company's established track record of supplying specialized pharmaceutical items such as oncology treatments, vaccines, and other prescription medications positions it as a key vendor for DLA's medical supply requirements across military facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FUJSX?
SPE2DB25FUJSX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FUJSX worth?
The government has obligated $12,341 on SPE2DB25FUJSX.
Is contract SPE2DB25FUJSX an order under another contract?
Yes. SPE2DB25FUJSX is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSX competed?
The extent of competition for SPE2DB25FUJSX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award